These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5. Lin CY; Jan YJ; Kuo LK; Wang BJ; Huo C; Jiang SS; Chen SC; Kuo YY; Chang CR; Chuu CP Cancer Sci; 2018 Nov; 109(11):3564-3574. PubMed ID: 30142696 [TBL] [Abstract][Full Text] [Related]
33. ATRA inhibits the proliferation of DU145 prostate cancer cells through reducing the methylation level of HOXB13 gene. Liu Z; Ren G; Shangguan C; Guo L; Dong Z; Li Y; Zhang W; Zhao L; Hou P; Zhang Y; Wang X; Lu J; Huang B PLoS One; 2012; 7(7):e40943. PubMed ID: 22808286 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy. Beebe-Dimmer JL; Isaacs WB; Zuhlke KA; Yee C; Walsh PC; Isaacs SD; Johnson AM; Ewing CE; Humphreys EB; Chowdhury WH; Montie JE; Cooney KA BJU Int; 2014 May; 113(5):830-5. PubMed ID: 24148311 [TBL] [Abstract][Full Text] [Related]
35. MEIS1 functions as a potential AR negative regulator. Cui L; Li M; Feng F; Yang Y; Hang X; Cui J; Gao J Exp Cell Res; 2014 Oct; 328(1):58-68. PubMed ID: 25158280 [TBL] [Abstract][Full Text] [Related]
36. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Axlund SD; Lambert JR; Nordeen SK Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772 [TBL] [Abstract][Full Text] [Related]
37. MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans. VanOpstall C; Perike S; Brechka H; Gillard M; Lamperis S; Zhu B; Brown R; Bhanvadia R; Vander Griend DJ Elife; 2020 Jun; 9():. PubMed ID: 32553107 [TBL] [Abstract][Full Text] [Related]
38. HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4. Jung C; Kim RS; Lee SJ; Wang C; Jeng MH Cancer Res; 2004 May; 64(9):3046-51. PubMed ID: 15126340 [TBL] [Abstract][Full Text] [Related]
39. Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target. Asim M; Massie CE; Orafidiya F; Pértega-Gomes N; Warren AY; Esmaeili M; Selth LA; Zecchini HI; Luko K; Qureshi A; Baridi A; Menon S; Madhu B; Escriu C; Lyons S; Vowler SL; Zecchini VR; Shaw G; Hessenkemper W; Russell R; Mohammed H; Stefanos N; Lynch AG; Grigorenko E; D'Santos C; Taylor C; Lamb A; Sriranjan R; Yang J; Stark R; Dehm SM; Rennie PS; Carroll JS; Griffiths JR; Tavaré S; Mills IG; McEwan IJ; Baniahmad A; Tilley WD; Neal DE J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26657335 [TBL] [Abstract][Full Text] [Related]
40. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth. Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]